1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kohda, D.
Inagaki, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
31
11928
11939
10.1021/bi00162a036
1445923
Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions.
1992
US
Biochemistry
BICHAW
0033
0006-2960
31
677
Structure of Epidermal Growth Factor Bound to Perdeuterated Dodecylphosphocholine Micelles Determined by Two-Dimensional NMR and Simulated Annealing Calculations
1992
US
Biochemistry
BICHAW
0033
0006-2960
30
4896
Characterization of Ph Titration Shifts for All the Nonlabile Proton Resonances in a Protein by Two-Dimensional NMR: The Case of Mouse Epidermal Growth Factor
1991
JA
J.Biochem.(Tokyo)
JOBIAO
0418
0021-924X
103
741
Tertiary Structure of Mouse Epidermal Growth Factor Determined by Two-Dimensional 1H NMR
1988
AT
Biochem.Int.
BIINDF
0758
0158-5231
16
647
A Comparative 1H NMR Study of Mouse Alpha(1-53) and Beta(2-53) Epidermal Growth Factors
1988
JA
J.Biochem.(Tokyo)
JOBIAO
0418
0021-924X
103
554
Complete Sequence-Specific 1H Nuclear Magnetic Resonance Assignments for Mouse Epidermal Growth Factor
1988
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6050.717
EPIDERMAL GROWTH FACTOR
1
man
polymer
no
no
NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELR
NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
house mouse
Mus
sample
10090
Mus musculus
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1994-01-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1992-03-24
REL
REL
10
BRUNGER
refinement
X-PLOR
ASN
1
n
1
ASN
1
A
SER
2
n
2
SER
2
A
TYR
3
n
3
TYR
3
A
PRO
4
n
4
PRO
4
A
GLY
5
n
5
GLY
5
A
CYS
6
n
6
CYS
6
A
PRO
7
n
7
PRO
7
A
SER
8
n
8
SER
8
A
SER
9
n
9
SER
9
A
TYR
10
n
10
TYR
10
A
ASP
11
n
11
ASP
11
A
GLY
12
n
12
GLY
12
A
TYR
13
n
13
TYR
13
A
CYS
14
n
14
CYS
14
A
LEU
15
n
15
LEU
15
A
ASN
16
n
16
ASN
16
A
GLY
17
n
17
GLY
17
A
GLY
18
n
18
GLY
18
A
VAL
19
n
19
VAL
19
A
CYS
20
n
20
CYS
20
A
MET
21
n
21
MET
21
A
HIS
22
n
22
HIS
22
A
ILE
23
n
23
ILE
23
A
GLU
24
n
24
GLU
24
A
SER
25
n
25
SER
25
A
LEU
26
n
26
LEU
26
A
ASP
27
n
27
ASP
27
A
SER
28
n
28
SER
28
A
TYR
29
n
29
TYR
29
A
THR
30
n
30
THR
30
A
CYS
31
n
31
CYS
31
A
ASN
32
n
32
ASN
32
A
CYS
33
n
33
CYS
33
A
VAL
34
n
34
VAL
34
A
ILE
35
n
35
ILE
35
A
GLY
36
n
36
GLY
36
A
TYR
37
n
37
TYR
37
A
SER
38
n
38
SER
38
A
GLY
39
n
39
GLY
39
A
ASP
40
n
40
ASP
40
A
ARG
41
n
41
ARG
41
A
CYS
42
n
42
CYS
42
A
GLN
43
n
43
GLN
43
A
THR
44
n
44
THR
44
A
ARG
45
n
45
ARG
45
A
ASP
46
n
46
ASP
46
A
LEU
47
n
47
LEU
47
A
ARG
48
n
48
ARG
48
A
TRP
49
n
49
TRP
49
A
TRP
50
n
50
TRP
50
A
GLU
51
n
51
GLU
51
A
LEU
52
n
52
LEU
52
A
ARG
53
n
53
ARG
53
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
TYR
3
A
N
TYR
3
A
O
HIS
22
A
O
HIS
22
A
N
MET
21
A
N
MET
21
A
O
THR
30
A
O
THR
30
A
N
SER
38
A
N
SER
38
A
O
THR
44
A
O
THR
44
2
A
A
HD21
H
ASN
SER
1
2
1.25
3
A
A
HH
HE1
TYR
TRP
37
49
1.22
6
A
A
H1
H
ASN
SER
1
2
1.29
1
A
TYR
37
0.081
SIDE CHAIN
1
A
ARG
41
0.314
SIDE CHAIN
1
A
ARG
45
0.307
SIDE CHAIN
1
A
ARG
48
0.310
SIDE CHAIN
1
A
ARG
53
0.189
SIDE CHAIN
2
A
ARG
41
0.311
SIDE CHAIN
2
A
ARG
45
0.205
SIDE CHAIN
3
A
TYR
37
0.095
SIDE CHAIN
3
A
ARG
41
0.311
SIDE CHAIN
3
A
ARG
45
0.271
SIDE CHAIN
3
A
ARG
48
0.244
SIDE CHAIN
3
A
ARG
53
0.319
SIDE CHAIN
4
A
TYR
37
0.092
SIDE CHAIN
4
A
ARG
41
0.316
SIDE CHAIN
4
A
ARG
45
0.099
SIDE CHAIN
4
A
ARG
48
0.290
SIDE CHAIN
4
A
ARG
53
0.176
SIDE CHAIN
5
A
TYR
10
0.067
SIDE CHAIN
5
A
TYR
37
0.077
SIDE CHAIN
5
A
ARG
41
0.315
SIDE CHAIN
5
A
ARG
45
0.276
SIDE CHAIN
5
A
ARG
48
0.267
SIDE CHAIN
5
A
ARG
53
0.125
SIDE CHAIN
6
A
TYR
37
0.075
SIDE CHAIN
6
A
ARG
41
0.298
SIDE CHAIN
6
A
ARG
45
0.077
SIDE CHAIN
6
A
ARG
48
0.267
SIDE CHAIN
6
A
ARG
53
0.318
SIDE CHAIN
7
A
TYR
10
0.079
SIDE CHAIN
7
A
TYR
37
0.096
SIDE CHAIN
7
A
ARG
41
0.172
SIDE CHAIN
7
A
ARG
45
0.190
SIDE CHAIN
7
A
ARG
48
0.217
SIDE CHAIN
7
A
ARG
53
0.318
SIDE CHAIN
8
A
TYR
37
0.083
SIDE CHAIN
8
A
ARG
41
0.286
SIDE CHAIN
8
A
ARG
45
0.322
SIDE CHAIN
8
A
ARG
48
0.315
SIDE CHAIN
8
A
ARG
53
0.232
SIDE CHAIN
9
A
TYR
37
0.084
SIDE CHAIN
9
A
ARG
41
0.269
SIDE CHAIN
9
A
ARG
45
0.262
SIDE CHAIN
9
A
ARG
48
0.265
SIDE CHAIN
9
A
ARG
53
0.300
SIDE CHAIN
10
A
TYR
37
0.070
SIDE CHAIN
10
A
ARG
41
0.297
SIDE CHAIN
10
A
ARG
45
0.314
SIDE CHAIN
10
A
ARG
48
0.189
SIDE CHAIN
1
5.64
0.90
109.00
114.64
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
1
-6.91
1.00
110.10
103.19
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
1
6.53
0.90
109.00
115.53
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
1
7.79
1.10
130.40
138.19
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
50
50
50
N
1
-6.17
1.00
107.30
101.13
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
50
50
50
N
2
-8.18
1.30
127.00
118.82
A
A
A
CB
CG
CD1
TRP
TRP
TRP
49
49
49
N
2
6.04
0.90
109.00
115.04
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
2
-6.51
1.00
110.10
103.59
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
2
6.22
0.90
109.00
115.22
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
2
7.95
1.10
130.40
138.35
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
50
50
50
N
2
-6.08
1.00
107.30
101.22
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
50
50
50
N
3
-7.88
1.30
127.00
119.12
A
A
A
CB
CG
CD1
TRP
TRP
TRP
49
49
49
N
3
5.88
0.90
109.00
114.88
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
3
-6.60
1.00
110.10
103.50
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
3
6.12
0.90
109.00
115.12
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
3
7.58
1.10
130.40
137.98
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
50
50
50
N
4
-6.44
1.00
110.10
103.66
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
49
49
49
N
4
6.42
0.90
109.00
115.42
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
4
6.68
1.10
130.40
137.08
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
49
49
49
N
4
-6.21
1.00
110.10
103.89
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
4
6.28
0.90
109.00
115.28
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
5
-6.57
1.00
110.10
103.53
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
49
49
49
N
5
6.42
0.90
109.00
115.42
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
5
7.34
1.10
130.40
137.74
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
49
49
49
N
5
-6.43
1.00
110.10
103.67
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
5
6.36
0.90
109.00
115.36
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
6
-10.49
1.30
127.00
116.51
A
A
A
CB
CG
CD1
TRP
TRP
TRP
49
49
49
N
6
5.82
0.90
109.00
114.82
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
6
-6.74
1.00
110.10
103.36
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
6
5.84
0.90
109.00
114.84
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
7
-8.29
1.30
127.00
118.71
A
A
A
CB
CG
CD1
TRP
TRP
TRP
49
49
49
N
7
5.77
0.90
109.00
114.77
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
7
-6.83
1.00
110.10
103.27
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
7
6.20
0.90
109.00
115.20
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
7
7.33
1.10
130.40
137.73
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
50
50
50
N
8
6.06
0.90
109.00
115.06
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
8
7.20
1.10
130.40
137.60
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
49
49
49
N
8
-7.05
1.00
110.10
103.05
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
8
6.49
0.90
109.00
115.49
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
9
-7.91
1.30
127.00
119.09
A
A
A
CB
CG
CD1
TRP
TRP
TRP
49
49
49
N
9
5.66
0.90
109.00
114.66
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
9
-6.92
1.00
110.10
103.18
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
9
6.47
0.90
109.00
115.47
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
10
-6.64
1.00
110.10
103.46
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
49
49
49
N
10
6.46
0.90
109.00
115.46
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
49
49
49
N
10
7.07
1.10
130.40
137.47
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
49
49
49
N
10
-6.40
1.00
110.10
103.70
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
50
50
50
N
10
6.46
0.90
109.00
115.46
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
50
50
50
N
1
A
A
CG
ND1
HIS
HIS
22
22
-0.105
0.015
1.369
1.264
N
1
A
A
CG
CD2
TRP
TRP
50
50
-0.103
0.017
1.432
1.329
N
2
A
A
CG
ND1
HIS
HIS
22
22
-0.105
0.015
1.369
1.264
N
3
A
A
CG
ND1
HIS
HIS
22
22
-0.104
0.015
1.369
1.265
N
3
A
A
CG
CD2
TRP
TRP
50
50
-0.103
0.017
1.432
1.329
N
4
A
A
CG
ND1
HIS
HIS
22
22
-0.103
0.015
1.369
1.266
N
4
A
A
CG
CD2
TRP
TRP
49
49
-0.105
0.017
1.432
1.327
N
5
A
A
CG
ND1
HIS
HIS
22
22
-0.102
0.015
1.369
1.267
N
5
A
A
CG
CD2
TRP
TRP
49
49
-0.104
0.017
1.432
1.328
N
6
A
A
CG
ND1
HIS
HIS
22
22
-0.101
0.015
1.369
1.268
N
7
A
A
CG
ND1
HIS
HIS
22
22
-0.103
0.015
1.369
1.266
N
7
A
A
CG
CD2
TRP
TRP
50
50
-0.103
0.017
1.432
1.329
N
8
A
A
CG
ND1
HIS
HIS
22
22
-0.106
0.015
1.369
1.263
N
9
A
A
CG
ND1
HIS
HIS
22
22
-0.104
0.015
1.369
1.265
N
10
A
A
CG
ND1
HIS
HIS
22
22
-0.105
0.015
1.369
1.264
N
10
A
A
CG
CD2
TRP
TRP
49
49
-0.105
0.017
1.432
1.327
N
1
A
SER
2
70.27
-18.90
1
A
TYR
3
42.13
95.54
1
A
PRO
7
-36.67
115.78
1
A
SER
9
-47.10
-17.56
1
A
TYR
10
-84.34
-78.49
1
A
ASP
11
27.25
37.97
1
A
ASN
16
22.14
106.50
1
A
SER
25
74.10
-64.96
1
A
ASP
27
35.67
31.84
1
A
CYS
33
-90.82
-149.63
1
A
VAL
34
-161.78
-161.26
1
A
ILE
35
-68.70
54.11
1
A
SER
38
-157.56
-157.97
1
A
ASP
40
-47.10
-98.03
1
A
CYS
42
-172.96
31.73
1
A
LEU
47
-56.97
72.50
1
A
ARG
48
-145.33
-89.82
1
A
TRP
49
-40.86
-80.14
1
A
GLU
51
48.11
20.43
1
A
LEU
52
63.63
-3.18
2
A
SER
2
172.38
-16.23
2
A
TYR
3
41.35
100.97
2
A
PRO
7
-38.62
115.18
2
A
SER
8
-38.60
-24.10
2
A
SER
9
-52.45
-8.73
2
A
TYR
10
-100.70
-74.69
2
A
ASP
11
35.34
39.95
2
A
ASN
16
49.02
103.23
2
A
SER
25
-51.20
-74.69
2
A
SER
28
-75.14
-162.69
2
A
THR
30
-150.70
-151.11
2
A
CYS
33
-58.05
-147.10
2
A
ILE
35
-67.82
29.62
2
A
SER
38
-165.94
-148.00
2
A
ASP
40
-53.23
-100.80
2
A
CYS
42
-172.04
22.67
2
A
THR
44
-69.94
98.16
2
A
LEU
47
-58.89
86.10
2
A
ARG
48
-172.80
-92.20
2
A
TRP
49
-23.89
-117.44
2
A
TRP
50
34.04
108.76
2
A
GLU
51
153.32
163.13
2
A
LEU
52
55.77
140.71
3
A
SER
2
-38.52
144.68
3
A
PRO
7
-38.88
146.49
3
A
SER
9
-47.42
-14.40
3
A
ASN
16
11.23
106.14
3
A
ASP
27
53.58
7.31
3
A
SER
28
-76.36
-157.77
3
A
CYS
33
-73.85
-144.53
3
A
VAL
34
-164.94
-164.15
3
A
ILE
35
-68.07
52.14
3
A
ASP
40
-49.14
-99.13
3
A
CYS
42
-173.22
30.83
3
A
GLN
43
-69.29
28.68
3
A
LEU
47
-57.65
100.48
3
A
ARG
48
171.96
-73.61
3
A
LEU
52
53.36
159.22
4
A
SER
2
54.73
17.13
4
A
TYR
3
37.47
107.62
4
A
PRO
7
-38.59
114.31
4
A
SER
8
-39.65
-24.52
4
A
SER
9
-48.51
-17.75
4
A
TYR
10
-83.84
-82.16
4
A
ASP
11
32.05
28.94
4
A
CYS
14
178.79
97.56
4
A
ASN
16
25.29
103.62
4
A
ASP
27
48.00
12.74
4
A
SER
28
-77.50
-162.03
4
A
CYS
33
-90.09
-149.74
4
A
ILE
35
-69.25
57.58
4
A
SER
38
-170.08
-159.84
4
A
ASP
40
-44.91
-89.49
4
A
CYS
42
-175.42
28.07
4
A
LEU
47
-60.51
70.69
4
A
ARG
48
-141.03
-93.08
4
A
TRP
49
-39.29
-84.32
4
A
TRP
50
-55.99
-70.21
4
A
GLU
51
57.63
3.98
4
A
LEU
52
52.78
171.50
5
A
SER
2
168.62
-85.17
5
A
TYR
3
51.48
106.44
5
A
PRO
7
-37.70
154.03
5
A
SER
9
-47.84
-17.28
5
A
ASN
16
21.12
100.84
5
A
SER
25
-41.39
-76.16
5
A
ASP
27
50.38
10.34
5
A
SER
28
-77.28
-168.05
5
A
CYS
33
-58.76
-152.92
5
A
VAL
34
-160.15
-162.94
5
A
SER
38
-163.15
-166.56
5
A
ASP
40
-49.31
-105.26
5
A
CYS
42
-176.24
29.41
5
A
LEU
47
-65.72
76.49
5
A
ARG
48
-138.79
-87.57
5
A
TRP
49
-39.59
-82.29
5
A
TRP
50
-53.02
95.50
5
A
LEU
52
-57.73
173.82
6
A
SER
2
71.52
-18.08
6
A
TYR
3
43.54
95.41
6
A
PRO
4
-58.76
100.84
6
A
PRO
7
-33.89
123.93
6
A
SER
9
-46.72
-16.67
6
A
TYR
10
-91.34
-87.01
6
A
ASP
11
29.68
31.22
6
A
ASN
16
31.79
100.23
6
A
SER
25
75.13
-59.96
6
A
CYS
33
-91.98
-149.96
6
A
VAL
34
-164.18
-164.88
6
A
ILE
35
-69.19
33.14
6
A
SER
38
-166.72
-162.53
6
A
ASP
40
-46.84
-90.17
6
A
CYS
42
-172.77
37.26
6
A
ASP
46
-44.38
-166.34
6
A
ARG
48
-130.24
-78.70
6
A
TRP
49
-27.23
-125.65
6
A
TRP
50
5.59
84.25
7
A
SER
2
53.50
5.85
7
A
TYR
3
34.30
100.21
7
A
PRO
7
-41.68
158.26
7
A
SER
9
-46.92
-17.99
7
A
TYR
10
-88.50
-79.19
7
A
ASP
11
33.35
25.59
7
A
ASN
16
8.53
103.44
7
A
SER
25
-54.75
-75.49
7
A
ASP
27
60.95
-0.66
7
A
SER
28
-75.77
-158.86
7
A
CYS
33
-69.57
-148.26
7
A
VAL
34
-164.00
-166.82
7
A
ILE
35
-66.15
58.74
7
A
SER
38
-160.22
-149.63
7
A
ASP
40
-62.95
-118.62
7
A
CYS
42
-171.20
31.97
7
A
GLN
43
-69.58
10.55
7
A
LEU
47
-61.43
69.31
7
A
ARG
48
-141.40
-80.36
7
A
TRP
49
-42.23
-79.02
7
A
GLU
51
-43.29
-93.93
8
A
SER
2
75.70
-39.35
8
A
TYR
3
46.19
108.58
8
A
PRO
7
-38.44
114.67
8
A
SER
9
-47.31
-17.65
8
A
TYR
10
-81.98
-84.55
8
A
ASP
11
28.05
35.10
8
A
ASN
16
27.68
95.02
8
A
SER
25
-43.04
-82.55
8
A
CYS
33
-58.66
-161.46
8
A
VAL
34
-161.92
-163.03
8
A
SER
38
-161.60
-163.94
8
A
ASP
40
-58.55
-111.93
8
A
CYS
42
-170.71
39.35
8
A
ARG
48
172.34
-72.70
8
A
TRP
49
-35.07
-90.17
8
A
TRP
50
-44.36
94.33
8
A
GLU
51
-169.66
-84.36
8
A
LEU
52
53.82
-73.05
9
A
SER
2
175.84
-2.37
9
A
TYR
3
35.19
101.98
9
A
PRO
4
-56.82
107.49
9
A
PRO
7
-33.14
142.29
9
A
SER
9
-46.51
-17.73
9
A
TYR
10
-91.25
-75.32
9
A
ASP
11
35.95
23.40
9
A
TYR
13
-138.86
-42.55
9
A
SER
25
166.94
-86.82
9
A
ASP
27
58.55
17.68
9
A
SER
28
-78.39
-167.66
9
A
CYS
33
-82.45
-145.76
9
A
VAL
34
-161.96
-165.35
9
A
ILE
35
-68.81
53.48
9
A
SER
38
-161.38
-165.87
9
A
ASP
40
-42.74
-89.12
9
A
CYS
42
-177.35
73.74
9
A
LEU
47
-62.40
72.28
9
A
ARG
48
-143.63
-86.47
9
A
TRP
49
-39.26
-72.78
9
A
TRP
50
-59.85
-77.66
9
A
GLU
51
58.42
177.58
10
A
TYR
3
53.04
105.37
10
A
PRO
7
-37.15
109.96
10
A
SER
8
-39.18
-25.57
10
A
TYR
10
-89.75
-70.27
10
A
ASP
11
35.21
31.28
10
A
ASN
16
37.86
87.33
10
A
SER
25
-42.05
-81.43
10
A
ASP
27
53.48
12.97
10
A
SER
28
-76.50
-162.10
10
A
CYS
33
-64.63
-152.57
10
A
VAL
34
-160.73
-163.48
10
A
SER
38
-161.24
-157.75
10
A
ASP
40
-45.47
-97.36
10
A
ARG
41
-77.60
-71.48
10
A
CYS
42
-173.03
36.57
10
A
LEU
47
-62.29
74.61
10
A
ARG
48
-140.55
-81.45
10
A
TRP
49
-47.67
-84.06
10
A
GLU
51
-149.92
-73.65
10
A
LEU
52
-33.93
115.36
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
EPIDERMAL GROWTH FACTOR (EGF) IN PH 2 SOLUTION (NMR, 10 STRUCTURES)
THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE STRUCTURES OF MOUSE EPIDERMAL GROWTH FACTOR IN ACIDIC AND PHYSIOLOGICAL PH SOLUTIONS
1
Y
N
disulf
2.019
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
20
A
SG
CYS
20
1_555
disulf
2.021
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
31
A
SG
CYS
31
1_555
disulf
2.018
A
CYS
33
A
SG
CYS
33
1_555
A
CYS
42
A
SG
CYS
42
1_555
GROWTH FACTOR
GROWTH FACTOR
EGF_MOUSE
UNP
1
1
P01132
MPWGRRPTWLLLAFLLVFLKISILSVTAWQTGNCQPGPLERSERSGTCAGPAPFLVFSQGKSISRIDPDGTNHQQLVVDA
GISADMDIHYKKERLYWVDVERQVLLRVFLNGTGLEKVCNVERKVSGLAIDWIDDEVLWVDQQNGVITVTDMTGKNSRVL
LSSLKHPSNIAVDPIERLMFWSSEVTGSLHRAHLKGVDVKTLLETGGISVLTLDVLDKRLFWVQDSGEGSHAYIHSCDYE
GGSVRLIRHQARHSLSSMAFFGDRIFYSVLKSKAIWIANKHTGKDTVRINLHPSFVTPGKLMVVHPRAQPRTEDAAKDPD
PELLKQRGRPCRFGLCERDPKSHSSACAEGYTLSRDRKYCEDVNECATQNHGCTLGCENTPGSYHCTCPTGFVLLPDGKQ
CHELVSCPGNVSKCSHGCVLTSDGPRCICPAGSVLGRDGKTCTGCSSPDNGGCSQICLPLRPGSWECDCFPGYDLQSDRK
SCAASGPQPLLLFANSQDIRHMHFDGTDYKVLLSRQMGMVFALDYDPVESKIYFAQTALKWIERANMDGSQRERLITEGV
DTLEGLALDWIGRRIYWTDSGKSVVGGSDLSGKHHRIIIQERISRPRGIAVHPRARRLFWTDVGMSPRIESASLQGSDRV
LIASSNLLEPSGITIDYLTDTLYWCDTKRSVIEMANLDGSKRRRLIQNDVGHPFSLAVFEDHLWVSDWAIPSVIRVNKRT
GQNRVRLQGSMLKPSSLVVVHPLAKPGADPCLYRNGGCEHICQESLGTARCLCREGFVKAWDGKMCLPQDYPILSGENAD
LSKEVTSLSNSTQAEVPDDDGTESSTLVAEIMVSGMNYEDDCGPGGCGSHARCVSDGETAECQCLKGFARDGNLCSDIDE
CVLARSDCPSTSSRCINTEGGYVCRCSEGYEGDGISCFDIDECQRGAHNCAENAACTNTEGGYNCTCAGRPSSPGRSCPD
STAPSLLGEDGHHLDRNSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCQTRDLRWWELRHAGYGQKHDIM
VVAVCMVALVLLLLLGMWGTYYYRTRKQLSNPPKNPCDEPSGSVSSSGPDSSSGAAVASCPQPWFVVLEKHQDPKNGSLP
ADGTNGAVVDAGLSPSLQLGSVHLTSWRQKPHIDGMGTGQSCWIPPSSDRGPQEIEGNSHLPSYRPVGPEKLHSLQSANG
SCHERAPDLPRQTEPVK
977
1029
1EPH
1
53
P01132
A
1
1
53
3
2
anti-parallel
anti-parallel
anti-parallel
A
SER
2
A
SER
2
A
PRO
4
A
PRO
4
A
VAL
19
A
VAL
19
A
ILE
23
A
ILE
23
A
SER
28
A
SER
28
A
ASN
32
A
ASN
32
A
TYR
37
A
TYR
37
A
SER
38
A
SER
38
A
THR
44
A
THR
44
A
ARG
45
A
ARG
45
1
P 1